Found: 30
Select item for more details and to access through your institution.
Comparison of FACS and PCR for Detection of BCMA-CAR-T Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 2, p. 903, doi. 10.3390/ijms23020903
- By:
- Publication type:
- Article
Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1005554
- By:
- Publication type:
- Article
Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome.
- Published in:
- Stem Cells, 2016, v. 34, n. 2, p. 357, doi. 10.1002/stem.2224
- By:
- Publication type:
- Article
Gemtuzumab ozogamicin plus midostaurin in combination with standard '7 + 3' induction therapy in newly diagnosed AML: Results from the SAL‐MODULE phase I study.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2254, doi. 10.1111/bjh.19436
- By:
- Publication type:
- Article
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 388, doi. 10.1111/bjh.17673
- By:
- Publication type:
- Article
Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes ( MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS).
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 5, p. 917, doi. 10.1111/bjh.14345
- By:
- Publication type:
- Article
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM‐3 antibody, in combination with decitabine or azacitidine in high‐ or very high‐risk myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E32, doi. 10.1002/ajh.27161
- By:
- Publication type:
- Article
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211019675
- By:
- Publication type:
- Article
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211019675
- By:
- Publication type:
- Article
In Vivo Expansion of Co-Transplanted T Cells Impacts on Tumor Re-Initiating Activity of Human Acute Myeloid Leukemia in NSG Mice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0060680
- By:
- Publication type:
- Article
Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 251, doi. 10.1007/s00262-021-02981-w
- By:
- Publication type:
- Article
MDS-404: Population Pharmacokinetics Modeling and Evaluation of Clinical Efficacy and Safety of Sabatolimab: Dose Selection and Dose-Response Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S349, doi. 10.1016/S2152-2650(21)01810-3
- By:
- Publication type:
- Article
MDS-420: Sabatolimab Plus Hypomethylating Agents (HMAs) in Patients with High-/Very High-risk Myelodysplastic Syndrome (HR/vHR-MDS) and Newly Diagnosed Acute Myeloid Leukemia (ND-AML): Subgroup Analysis of a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S350, doi. 10.1016/S2152-2650(21)01811-5
- By:
- Publication type:
- Article
Poster: MDS-404: Population Pharmacokinetics Modeling and Evaluation of Clinical Efficacy and Safety of Sabatolimab: Dose Selection and Dose-Response Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S230, doi. 10.1016/S2152-2650(21)01448-8
- By:
- Publication type:
- Article
Poster: MDS-420: Sabatolimab Plus Hypomethylating Agents (HMAs) in Patients with High-/Very High-risk Myelodysplastic Syndrome (HR/vHR-MDS) and Newly Diagnosed Acute Myeloid Leukemia (ND-AML): Subgroup Analysis of a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S230, doi. 10.1016/S2152-2650(21)01447-6
- By:
- Publication type:
- Article
Long-term in vivo imaging reveals tumor-specific dissemination and captures host tumor interaction in zebrafish xenografts.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-69956-2
- By:
- Publication type:
- Article
A rare case for gas in the heart: diagnosis and treatment.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
- Published in:
- Genes, Chromosomes & Cancer, 2003, v. 37, n. 3, p. 237, doi. 10.1002/gcc.10219
- By:
- Publication type:
- Article
Peptidyl prolyl cis/trans isomerase activity on the cell surface correlates with extracellular matrix development.
- Published in:
- Communications Biology, 2019, v. 2, n. 1, p. N.PAG, doi. 10.1038/s42003-019-0315-8
- By:
- Publication type:
- Article
Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphoma.
- Published in:
- American Journal of Cancer Research, 2024, v. 14, n. 6, p. 2905, doi. 10.62347/LLXR8002
- By:
- Publication type:
- Article
Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse.
- Published in:
- Cancer Management & Research, 2022, v. 14, p. 547, doi. 10.2147/CMAR.S339846
- By:
- Publication type:
- Article
<sup>188</sup>Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning and in-vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantation.
- Published in:
- British Journal of Haematology, 2010, v. 148, n. 6, p. 910, doi. 10.1111/j.1365-2141.2009.08025.x
- By:
- Publication type:
- Article
Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: summary of three phase I studies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Kleinzelliges Lungenkarzinom – Etablierte Standards und neue Ansätze.
- Published in:
- Der Internist, 2022, v. 63, n. 7, p. 724, doi. 10.1007/s00108-022-01362-4
- By:
- Publication type:
- Article
Routine Molecular Pathology Diagnostics in Precision Oncology.
- Published in:
- Deutsches Ärzteblatt International, 2021, v. 118, n. 15, p. 255
- By:
- Publication type:
- Article
In Vitro Functionality and Endurance of GMP-Compliant Point-of-Care BCMA.CAR-T Cells at Different Timepoints of Cryopreservation.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1394, doi. 10.3390/ijms25031394
- By:
- Publication type:
- Article
Preparing Patients With Myelodysplastic Syndrome for Transplant When Is Pre-transplant Cytoreductive Therapy Appropriate?
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 3, p. 329, doi. 10.1007/s11899-015-0276-z
- By:
- Publication type:
- Article